Join us to learn how lncRNA impacts cancer and microRNA regulation!


Long noncoding RNA are a non-protein-coding RNA species >200 nt in length that have been the subject of intense scrutiny recently. Research in the last several years has revealed roles for lncRNA in gene regulation at many levels – transcription, post-transcription, and in epigenetic modification. Many lncRNAs are dysregulated in various cancer types and are closely related to tumorigenesis, metastasis and prognosis or diagnosis.

On Wednesday, April 27, join us for a free webinar discussing the regulatory and functional roles of lncRNA in cancers, with a particular focus on how lncRNAs impact microRNA expression and function! We’ll also talk about a new qPCR-based lncRNA platform for lncRNA detection and profiling, as well as an application for serum lncRNA as a potential biomarker for lung cancer.

Watch the Recording!

Ali Bierly

Ali Bierly, PhD is a Global Market Manager in Translational Sciences at QIAGEN, and has written on a number of scientific topics in the biotech industry as the author of QIAGEN's Reviews Online. She received her PhD from Cornell University in 2009, studying the immune response to a protozoan parasite, Toxoplasma gondii. Ali has a keen interest in the emerging importance of microRNA and other circulating nucleic acids as biomarkers for disease.

Your email address will not be published. Required fields are marked *